Ross Muken is a Senior Managing Director and heads ISI’s Life Science Tools & Diagnostics/Health Care Technology & Distribution Research Team. Mr. Muken has been recognized by Institutional Investor, Greenwich Associates, Thomson StarMine, Forbes and Bloomberg for his insightful fundamental research and highly accurate financial modeling. Prior to joining ISI in 2012, Mr. Muken held various titles in equity research at Thomas Weisel Partners and Deutsche Bank Securities Inc., where he was mostly recently a Managing Director and headed the health care services & technology team. Earlier in his career, Mr. Muken was a member of Banc of America Securities’ Mergers & Acquisitions Group. Mr. Muken graduated magna cum laude from Boston University’s School of Management in 2001.
Diagnostics Headwinds Could Signal to Growing M&A Activity
September 09, 2014
Significant M&A Across Health Care
July 22, 2013
Health Care Services & Tech Outlook - Ross Muken - Deutsche Bank Securities, Inc.
November 15, 2010